What's in Imprimis Pharmaceuticals, Inc.'s pipeline?

Imprimis Pharmaceuticals, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Imprimis Pharmaceuticals, Inc.'s portfolio?

Top competitors by shared drug class: Depomed, Dong-A ST Co., Ltd., Handok Inc., Kunming Baker Norton Pharmaceutical Sales Co., Ltd., LEO Pharma.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/imprimis-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Imprimis Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief

Imprimis Pharmaceuticals, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Topical Ketoprofen 10% Cream	Topical Ketoprofen 10% Cream	phase 3	NSAID (nonsteroidal anti-inflammatory drug)	COX-1, COX-2	Pain Management / Rheumatology

Therapeutic area mix

Pain Management / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Depomed · 1 shared drug class
Dong-A ST Co., Ltd. · 1 shared drug class
Handok Inc. · 1 shared drug class
Kunming Baker Norton Pharmaceutical Sales Co., Ltd. · 1 shared drug class
LEO Pharma · 1 shared drug class
Novartis · 1 shared drug class
Pfizer · 1 shared drug class
University of South Alabama · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Imprimis Pharmaceuticals, Inc.:

Cite this brief

Drug Landscape (2026). Imprimis Pharmaceuticals, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/imprimis-pharmaceuticals-inc. Accessed 2026-05-16.